The global alpha emitters market was valued at approximately USD 5000 million in 2017 and is expected to register a CAGR of approximately 9% during the forecast period. North America holds the largest geographical market, with a share of approximately 47% of the global market.
Global Alpha Emitters Market Major Key players: IBA Group, Lantheus Medical Imaging, Triad Isotopes, Siemens Healthcare (Petnet Solutions), NTP Radioisotopes, Others, etc.
Global Alpha Emitters Market Analysis By Type of Radionuclide: Terbium (Tb-149), Astatine (At-211), Bismuth (Bi-212), Actinium (Ac-225), Radium (Ra-223), Lead (Pb-212), Bismuth (Bi -213).
Global Alpha Emitters Market Analysis By Medical Application: Glioma, Melanoma, Pancreatic Cancer, Ovarian Cancer, Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Others
Request For Sample here: https://www.marketinsightsreports.com/reports/0220247068/global-alpha-emitters-market-segmented-by-type-of-radionuclide-medical-application-and-geography-growth-trends-and-forecasts-2018-2023/inquiry
Increasing Incidence of Cardiac and Cancer Ailments
The American Cancer Society, the leading body in cancer stats and figures, reported 1,685,210 estimated new cancer cases and 595,690 deaths, owing to cancer, in 2016. The US National Cancer Institute reported that more than 60% of the worlds new cancer cases occur in Africa, Asia, and Central and South America. About 70% of the worlds cancer deaths also occur in these regions. International Agency for Research on Cancer (IARC) predicts – by 2030, the global burden is expected to grow to 21.7 million new cancer cases and 13 million cancer deaths simply due to a growth and aging of the population, leaving aside factors, like smoking, poor diet, physical inactivity, and fewer childbirths, in economically developing countries.
Any other doubts about cancer being one of the major life threatening diseases in present time can be cleared by looking at the data presented by WHO, which states that 8.2 million people die every year from cancer, an estimated 13% of all deaths, worldwide. An increase of 70% is predicted in new cases of cancer expected over the next two decades and to top it all, more than 100 cancer types exist, requiring unique diagnosis and treatment. This global and extensive threat of cancer remains a major market driver for new cancer therapies involving alpha emitters and monoclonal antibody.
Stringent regulatory framework
The global production of radiopharmaceuticals, unlike conventional pharmaceuticals production, is still in the nascent stage. Implementing cGMP guidelines, which are applicable for the drug industry, is both difficult and expensive. For small-scale manufacturers of radiopharmaceuticals, ensuring cGMP compliance is a demanding task. Application of clean room requirements in radioisotope laboratories is technically demanding as they are required to conform to both radiological and pharmaceutical safety standards.
Additionally, there are problems associated with the transportation of radioactive materials. Some countries follow a practice of holding up all the cargo at the airports, at times, for a pre-destined period (24 to 48 hours) before being loaded on the plane, as part of security check standards. This practice affects the radiopharmaceuticals due to additional decay losses, especially when dealing with short-lived radioactive materials. Hence, stringent regulatory framework, delays in transportation, and lack of transportation compliance, along with the fragile nature of radiopharmaceuticals with short half-life, are impeding the growth of the alpha emitters market.
US is the Largest Consumer Market for Radiopharmaceuticals
The market for alpha-emitters in the United States is growing rapidly. The United States accounted for the largest global market share in 2017. The high-end research trend in the United States, coupled with high investments in healthcare research and abundant knowledge in cancer research, is the key factor propelling the growth of the market in the country.
The government initiatives and trends toward the adoption of technologically-advanced products for healthcare are also fuelling the market growth. The United States also has the largest market for monoclonal antibodies. Many researches are being carried on by radiolabelling monoclonal antibodies with alpha emitters. The drug with high efficacy will create a huge market due to high unmet need of curative cancer therapeutics. Actinium Pharmaceuticals, based in New York, United States, is one of the key players in this market and is carrying out breakthrough research in the field.
Browse Full Report at: https://www.marketinsightsreports.com/reports/0220247068/global-alpha-emitters-market-segmented-by-type-of-radionuclide-medical-application-and-geography-growth-trends-and-forecasts-2018-2023
Regions Covered in this report are as Follows:
United States, North America (Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Columbia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa), RoW (Rest of World).
Key Developments:
- December 2017: The US Department of Energys National Nuclear Security Administration (DOE/NNSA) and South African Nuclear Energy Corporations NTP Radioisotopes SOC Ltd (NTP) completed the conversion of their critical medical isotope molybdenum-99 (Mo-99) production process from highly-enriched uranium (HEU) to low-enriched uranium (LEU)
- November 2017: Actinium Pharmaceuticals launched the AWE Program aka Actinium Warhead Enabling Program to enable collaborations based on Its Actinium-225 Technology Platform
- November 2017: Alpha Tau Medical entered a collaboration with IRST Italy to treat its first cancer patients. This is a significant progress toward international expansion. It will enable the availability of Alpha DaRT radiotherapy not only in Israel but in Europe, Asia, as well as the United States.
Reasons to Purchase this Report:
- The report analyses how the stringent emission control norms will drive the global Alpha Emitters market.
- Analyzing various perspectives of the market with the help of Porters five forces analysis.
- Study on the product type that is expected to dominate the Alpha Emitters Market.
- Study on the regions that are expected to witness fastest growth during the forecast period.
- Identify the latest developments, market shares and strategies employed by the major players of Alpha Emitters Market.
- 3 months analyst support along with the Market Estimate sheet (in excel).
Customization of the Report:
This report can be customized to meet the desired requirements. Please connect with our analyst, who will ensure that you get a report that suits your needs.
About Us:-
MarketInsightsReports provides syndicated market research reports to industries, organizations or even individuals with an aim of helping them in their decision making process. MarketInsightsReports is your single point market research source for all industries including pharmaceutical, chemicals and materials, energy resource, automobile, IT, technology and media, food and beverages, and consumer goods, among others.
Contact us for your special interest research needs @[email protected] and we will get in touch with you within 24hrs and help you find the market research report you need.
+1 (704) 266-3234 | [email protected]
Connect With us on:
https://www.linkedin.com/company/13411016/
https://www.facebook.com/marketinsightsreports/
https://twitter.com/MIRresearch
SOURCE The Financial Consulting https://thefinancialconsulting.com/
